FLJ25758


Early-Onset Alzheimer's Disease (flj25758)

Description

Early-onset Alzheimer's disease (flj25758) is a rare form of Alzheimer's disease that affects individuals under the age of 65. It is characterized by progressive cognitive decline, memory loss, and impaired judgment. Individuals with flj25758 may also experience behavioral changes, such as agitation, irritability, and apathy.

Associated Diseases

flj25758 is associated with several other conditions, including:

  • Down syndrome: Individuals with Down syndrome have an increased risk of developing flj25758.
  • Familial Alzheimer's disease: Certain genetic mutations, such as the presenilin 1 (PSEN1) mutation, are linked to both early- and late-onset Alzheimer's disease.
  • Apolipoprotein E (APOE) ε4 allele: The APOE ε4 allele is a genetic risk factor for both flj25758 and late-onset Alzheimer's disease.

Did you Know ?

Approximately 1% of all Alzheimer's disease cases are considered early-onset. This means that the majority of individuals with Alzheimer's disease develop the condition after the age of 65.



Disclaimer: The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.